You are here: Industry Insights > Products Guide > Urgent Sourcing Needs of【CPhI.cn】2017.3.7

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Brexpiprazole Intermediate CAS:70500-72-0

Brexpiprazole CAS:913611-97-9

3-BROMOPHENANTHRENE

2-FLUORO-4-(TRIFLUOROMETHYL)BENZOPHENONE

3-BROMO-4-FLUOROBIPHENYL

9-TRIFLUOROACETYLANTHRACENE

Urgent Sourcing Needs of【CPhI.cn】2017.3.7

en-cphi.cnMarch 07, 2017

Tag: CPhI , Sourcing Needs

Favorites

【CPhI.cn】provides the free-of-charge One-to-One Matching Service every week. Your dedicated client service officer collects your sourcing needs and searches suitable suppliers for you to improve your sourcing efficiency greatly.

The validity of the sourcing needs lasts one week.

If your company could provide the following medical and hospital supplies, you can email the product name to Miki. She will reply you with the detailed information including the buyers' contact information.

Contact Person: Miki

Email: Miki.Zhou@ubmsinoexpo.com

Tel: 86-21-33392254

ID	Name of the Product	CAS No.	Quantity	Details	Country
1	Iron		18 mg	you are kindly requested to quote us for 1000 Kg of ingredients which will mention	Iran
1	Phosphoric acid, polymer with 4,4-(1-methylethylidene)bis(phenol) and 2,2-((1-methylethylidene)bis(4,1-phenyleneoxymethylene))bis(oxirane)	64346-82-3		Quantity:5 kgsQuality Standards: -Packing: Place of Origin:Purity:Standard:Detailed Description: to be used in coating formulations	India
2	Cyclohexanone,O-(trans-4-amino-4-methylcyclohexyl)oxime	792914-30-8		Quantity: 100 kgsQuality Standards: 99% purityPacking: standard export pack in hdpe drumsPlace of Origin: indiaPurity: 99%Standard:Detailed Description: pl provide COA	India
3	N N' bis (imidazolyl) hexane	69506-88-3	25 Kilogram	Quantity: 25gm Quality Standards: purity required and COAPacking: shipping by DHL or equivalentPlace of Origin: requiredPurity: requiredStandard: Detailed Description: Dear Sales, we wish to purchase 25 gm of the above N N' bis (imidazolyl) hexane CAS 69506-88-3.Looking forward to your soonest reply, Thanks, Jonathan Goldstein, tel: +972507303821Please send PI to contact:Jonathan Goldstein, 3GSolar Photovoltaics Ltd., 3 Hamape St., Har Hotzvim Technology Park,Jerusalem 9777403, Israel, tel: +972737073755, +972504568706Material may be sent using our DHL courier account 953984536 (in name of Israel Cargo Logistics)	Israel

Previous:PTC Therapeutics Announces FDA Acknowledgment of New Drug Application Filing for Translarna for the

Next:New research reveals Asia as preferred destination for clinical trials

Research and Application of Artemisia Argyi

XiaonishaAugust 12, 2024

Mugwort, also known as fragrant mugwort or Artemisia argyi, is a herbaceous plant belonging to the Compositae family.

Research Progress on the Application of Biologics in Pediatric Asthma

XiaomichongJuly 19, 2024

Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives

XiaomichongJuly 19, 2024

Urgent Sourcing Needs of【CPhI.cn】2017.3.7 | Pharmasources.com

Research and Development Status and Progress of Antibody Technology (Part Ⅱ)

XiaomichongJuly 18, 2024

Antibody-based biological therapeutic drugs have been playing an increasingly important role in biopharmaceuticals due to their strong targeting, good specificity, and significant therapeutic effects.

Urgent Sourcing Needs of【CPhI.cn】2017.3.7

Related News

Research and Application of Artemisia Argyi

Research Progress on the Application of Biologics in Pediatric Asthma

Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives

Research and Development Status and Progress of Antibody Technology (Part Ⅱ)

You may like
More>>

Urgent Sourcing Needs of【CPhI.cn】2017.3.7

Related News

Research and Application of Artemisia Argyi

Research Progress on the Application of Biologics in Pediatric Asthma

Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives

Research and Development Status and Progress of Antibody Technology (Part Ⅱ)

You may likeMore>>

You may like
More>>